ISOL.CN - Isodiol International Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.2000
+0.0100 (+5.26%)
At close: 3:42PM EST
Stock chart is not supported by your current browser
Previous Close0.1900
Open0.1850
Bid0.1850 x 0
Ask0.2000 x 0
Day's Range0.1850 - 0.2000
52 Week Range0.1500 - 1.6900
Volume44,445
Avg. Volume94,979
Market Cap9.778M
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)-2.6790
Earnings DateAug 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Isodiol International Inc. Provides Shareholder Update

    The company achieved strong revenue growth during the year, only to have this positive momentum halted during the last several months by a few small, however significant impacts of supply and demand. Unfortunately, this increased competition had an adverse effect on the bulk ingredient pricing model, resulting in record low margins across the industry and ultimately forcing a pivot in our sales strategies and operations to focus on branded finished products.

  • ACCESSWIRE

    Isodiol International Inc. Reports Second Quarter 2020 Financial Results

    VANCOUVER, BC / ACCESSWIRE / December 3, 2019 / Isodiol International Inc. (CSE:ISOL)(OTCQB:ISOLF)(FSE:LB6B.F) (the "Company" or "Isodiol"), announces that it has filed its consolidated financial statements and MD&A for the three months ended September 30, 2019 and issues shares to settle debt. The Company has reported revenues of $1.878M for its second quarter. The Company attributes the decrease in revenue primarily to management restructuring and the continued focus on long term, higher margin growth.

  • ACCESSWIRE

    Isodiol International Inc. Announces Successful Launch of Iso-Sport Products at The Vitamin Shoppe

    VANCOUVER, BC / ACCESSWIRE / October 9, 2019 / Isodiol International Inc. (CSE:ISOL) (OTCQB:ISOLF) (FSE:LB6B.F) (the "Company" or "Isodiol"), announces it has entered into a strategic relationship with Vitamin Shoppe, Inc. (VSI) ("The Vitamin Shoppe") for the launch of the Company's Iso-Sport products. Iso-Sport will serve as a leading brand of sports performance cannabinoid (CBD) hemp extract products at The Vitamin Shoppe. The Vitamin Shoppe is an omni-channel specialty retailer of nutritional products that continues to expand its CBD hemp extract offerings to meet consumer demand and serve as a trusted retailer of quality health and wellness supplements.

  • ACCESSWIRE

    Isodiol International Inc. Announces the Launch of Its Pawceuticals Brand

    VANCOUVER, BC / ACCESSWIRE / October 4, 2019 / Isodiol International Inc. (CSE:ISOL) (OTCQB:ISOLF) (FSE:LB6B.F) (the "Company" or "Isodiol"), announces that Pawceuticals, the CBD-based product line that naturally helps to restore a pet's health and overall wellness, is now available to purchase across the United States. The Pawceuticals functional CBD pet products are designed for dogs and cats and are scientifically formulated with a proprietary blend of adaptogens that may aid in comfort, calming, healthy gums support, immune support, itch support, joint support, kennel cough support, kidney support, liver support, urinary support and anti-aging. The Company's products are now available online and is also in the process of building their retail channels as well.

  • ACCESSWIRE

    Isodiol International Inc. Announces Appointment of Andrew Alvis as President

    VANCOUVER, BC / ACCESSWIRE / October 3, 2019 / Isodiol International Inc. (CSE:ISOL)(OTCQB:ISOLF)(FSE:LB6B.F) (the "Company" or "Isodiol"), announces the appointment of Andrew Alvis to serve as the Company's President. Mr. Alvis has diverse experience in all aspects of leadership, operational efficiency and revenue growth. Andrew held the position of Senior Finance Executive at Bank of America where he managed all accounting and finance system impacts for each acquisition as well as implementing strategies across mortgage servicing platforms to accommodate home loan delinquencies driven by the financial crisis of 2008.

  • GlobeNewswire

    Isodiol International Inc. Reports First Quarter 2020 Financial Results

    Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that it has filed its consolidated financial statements and MD&A for the three months ended June 30, 2019. The Company has reduced its operational expenditures by $3M compared to the three months ended June 30, 2018 and by $13M compared to the most recently completed three months ended March 31, 2019.

  • GlobeNewswire

    Isodiol International Inc. Reports Fiscal Year 2019 Audited Financial Results

    Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that it has filed its audited consolidated financial statements and MD&A for the year ended March 31, 2019.

  • GlobeNewswire

    Isodiol International Inc Provides an Update on the Delay in Filing Its Audited Financial Statements

    The Company obtained a management cease trade order dated July 30, 2019 from the relevant securities regulators as contemplated by National Policy 12-203 Management Cease Trade Orders of the Canadian Securities Administrators. The delay of the Filings resulted from delays in the Company obtaining access to accounting information following dispositions of subsidiaries over which the Company no longer has management influence.  The Company notes the audit is nearly complete and continues to expect to file the Filings on or before August 16, 2019. The Company will comply with the requirements of the alternative information guidelines set out in the National Policy.   The Company is not subject to any insolvency proceedings.

  • GlobeNewswire

    Isodiol International Inc. - Delay In Filing Audited Financial Statements - Obtains Management Cease Trade Order from BCSC

    Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), today announces a delay in the filing of its audited annual financial statements, related management’s discussion and analysis and supporting officer certificates for the financial year ended March 31, 2019 (the “Filings”).  The Filings are required to be made with the relevant securities regulatory authorities on or before July 29, 2019. The anticipated delay of its Filings is a result of delays in getting access to accounting information pursuant to dispositions of subsidiaries for which the Company no longer has management influence over. The Company notes that such delays have been resolved and the Company is now in the final stages of the audit and anticipates completing its Filings before August 16, 2019.

  • GlobeNewswire

    Isodiol International Inc. Announces Termination of Agreements With Carlsbad Naturals LLC

    VANCOUVER, British Columbia, July 18, 2019 -- Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”),  announces that the asset.

  • GlobeNewswire

    Isodiol International Inc. Announces 2018 AGM Voting Results; Provides Update on Partnership with the Asian American Trade Associations Council (AATAC)

    VANCOUVER, British Columbia, June 10, 2019 -- Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), today announces the voting.

  • GlobeNewswire

    Isodiol International Inc. Announces Notice of Annual General Meeting and Issues Updates on Mexico Operations and Restructuring Efforts

    Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that it will hold its annual general meeting of the Company's shareholders (the "Meeting") at 10:00 a.m. (Central Time) on June 6, 2019, at the Westin Santa Fe Hotel (Ballroom A) in Mexico City, Mexico.

  • GlobeNewswire

    Isodiol International Inc. Continues Its FY2020 Trade Show Program at the ECRM Pet EPPs Trade Conference Through May 01, 2019 in Itasca, Illinois

    Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is exhibiting at The Efficient Collaborative Retail Marketing Company (“ECRM”) Efficient Program Planning Sessions (“EPPS”): Pet EPPS, through May 01, 2019.  This event also marks the debut of Pawceuticals, the Company’s CBD-based product line that naturally aids in restoring a pet’s health. The EPPS within the ECRM event series allow vendors to have direct discussions with more than 80 retailers and other brands about business objectives, such as product launches, marketing campaigns, and more.

  • Market Exclusive

    Isodiol Rolls Out Cannabis Vending Machine in Selected Powerhouse Gym Locations

    Isodiol International Inc (OTCMKTS:ISOLF) is launching its first CBD vending machines across selected Powerhouse Gym locations in the U.S. The launch is part of the company’s vending machine initiative aimed at increasing convenience of accessing the company’s product. Isodiol/Powerhouse Partnership Isodiol is leveraging on its partnership with Powerhouse Gym announced in September last year. Through […]The post Isodiol Rolls Out Cannabis Vending Machine in Selected Powerhouse Gym Locations appeared first on Market Exclusive.

  • GlobeNewswire

    Isodiol International Inc. Commences Vending Machine Program for Iso-Sport™ Products with Initial Launch in 20 Powerhouse Gym Locations

    Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces the commencement of its cannabidiol (CBD) vending machine program with an initial launch of Iso-Sport™ products in 20 Powerhouse Gym (“Powerhouse”) locations across the United States.  This announcement follows Isodiol’s  September 14, 2018 announcement that it entered into an agreement with Powerhouse to be the preferred vendor of CBD performance products in Powerhouse gyms. Powerhouse is one of the largest health club licensing organizations in the world, with over 1.2 million gym members.  Today, Powerhouse continues to experience substantial growth opportunities, allowing the Company to target a growing consumer base for CBD products.

  • CNW Group

    IIROC Trade Resumption - ISOL

    IIROC Trade Resumption - ISOL

  • GlobeNewswire

    Isodiol International Inc. Announces the Sale of BSPG Laboratories Ltd. and Conclusion of Its Fiscal Year 2019 Business Restructurings

    Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) today announced the sale of its wholly owned subsidiary BSPG Laboratories Ltd. (“BSPG”) to a U.K. based private equity group (“buyer”) for US$14,000,000 in cash installments.  As a part of the transaction, Isodiol has secured an off-take supply agreement with the buyer to ensure continued distribution of its Purodiol and Isodiolex products.

  • CNW Group

    IIROC Trading Halt - ISOL

    IIROC Trading Halt - ISOL

  • GlobeNewswire

    Isodiol International Inc. Launches Its FY2020 Trade Show Program at the ECRM Orlando Trade Conference, March 31 – April 3, 2019 in Orlando, Florida

    Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) today announced the launch of its fiscal year 2020 trade show program, presenting the CBD Naturals® brands in each product category of the Weight Management, Sports Nutrition, Vitamin & Hemp Solutions EPPS of the ECRM Trade Conference in Orlando, Florida. The Efficient Collaborative Retail Marketing Company, LLC (“ECRM”) helps buyers and suppliers increase productivity, optimize product assortments, and enhance collaboration efforts through service offerings that include product discovery, category development, and category planning.  In addition, the Efficient Program Planning Sessions (“EPPS”) within the ECRM event series allow vendors to have direct discussions with more than 80 retailers and other brands about business objectives, such as product launches, marketing campaigns, and more.

  • GlobeNewswire

    Isodiol International Inc. Announces Creditor Approval of Arrangement and Receipt of Final Order for Arrangement with Creditors

    VANCOUVER, British Columbia, March 22, 2019 -- Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is pleased to announce that at.

  • GlobeNewswire

    Isodiol International Inc. Launches RapidCBD™ and Iso-Sport™ Brands into Holland & Barrett International, the Largest Health and Wellness Retailer in Europe

    The launch has commenced online and more than 45,000 units are expected to be available in up to 800 Holland & Barrett stores by the end of March, 2019 throughout the United Kingdom and the Republic of Ireland.  Holland & Barrett is the largest health and wellness retailer in Europe, operating more than 1,300 stores, 10 million customer loyalty program members, and US$800 million in annual revenues. The RapidCBD™ and Iso-Sport™ food supplement and cosmetic skin care products contain Isodiol’s proprietary ISO99™ hemp extract and botanical blends that work synergistically to provide positive health and wellness benefits to the body and mind.  All of the products in Isodiol’s program for Holland & Barrett are specially formulated for the U.K. and E.U. markets.

  • GlobeNewswire

    Isodiol International Inc. Co-Sponsors at ASD Market Week Alongside Asian American Trade Associations Council (AATAC)

    Isodiol and AATAC are showcasing the recently acquired Fast CBD Relief™ brand at the Las Vegas Convention Centre from March 17-20. VANCOUVER, British Columbia, March 19, 2019 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol) today announced it is exhibiting at the ASD Market Week (“ASD”) alongside the Asian American Trade Associations Council (“AATAC”). ASD is the most comprehensive trade show for consumer merchandise in the U.S. As the leading B2B trade show in Las Vegas, ASD brings the world’s widest variety of retail merchandise together in one efficient shopping experience.

  • GlobeNewswire

    Isodiol International Inc. Reports Fiscal Q3 2019 Financial Results with Revenue in Excess of $7.1 Million

    VANCOUVER, British Columbia, March 04, 2019 -- Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) announces its financial and.